Two cases of response to pembrolizumab in epidermal growth factor receptor mutated lung adenocarcinoma patients with programmed death-ligand 1 overexpression. - Uenami T; Ishijima M; Kanazu M; Kurebe H; Edahiro R; Nishida K; Akazawa Y; Yano Y; Yamaguchi T; Mori M (Annals of translational medicine, 2018)